Test Bank
Pharmacotherapy: A Pathophysiologic Approach,11th Edition By Joseph T. Dipiro, Gary C.
Yee, L. Michael Posey, Stuart T. Haines, Thomas D. Nolin, Vicki Ellingrod ||All Chapters With
Verified Answers
11th edition
,table of contents
chapter 1: health literacy and medication use .................................................................................................................... 6
chapter 2: cultural competency ......................................................................................................................................... 11
chapter 3: medication safety principles and practices ...................................................................................................... 16
chapter 4: clinical pharmacokinetics and pharmacodynamics ....................................................................................... 22
chapter 5: pharmacogenetics............................................................................................................................................ 27
chapter 6: pediatrics ......................................................................................................................................................... 33
chapter 7: geriatrics ......................................................................................................................................................... 40
chapter 8: palliative care .................................................................................................................................................. 45
chapter 9: clinical toxicology............................................................................................................................................ 51
chapter 10: clinical management of potential bioterrorism-related conditions................................................................ 56
chapter 11: cardiovascular testing ................................................................................................................................... 61
chapter 12: cardiac arrest ................................................................................................................................................ 61
chapter 13: hypertension .................................................................................................................................................. 65
chapter 14: chronic heart failure ...................................................................................................................................... 70
chapter 15: acute decompensated heart failure ................................................................................................................ 73
chapter 16: stable ischemic heart disease......................................................................................................................... 77
chapter 17: acute coronary syndromes ............................................................................................................................. 80
chapter 18: the arrhythmias .............................................................................................................................................. 85
chapter 19: venous thromboembolism............................................................................................................................... 87
chapter 20: stroke.............................................................................................................................................................. 89
chapter 21: dyslipidemia .................................................................................................................................................. 93
chapter 22: peripheral arterial disease ............................................................................................................................ 95
chapter 23: use of vasopressors and inotropes in the pharmacotherapy of shock............................................................ 96
chapter 24: hypovolemic shock ....................................................................................................................................... 100
chapter 25: introduction to pulmonary function testing ................................................................................................. 103
chapter 26: asthma .......................................................................................................................................................... 106
chapter 27: chronic obstructive pulmonary disease ....................................................................................................... 108
chapter 28: pulmonary arterial hypertension ................................................................................................................. 110
chapter 29: cystic fibrosis ............................................................................................................................................... 111
chapter 30: drug-induced pulmonary diseases ............................................................................................................... 113
chapter 31: evaluation of the gastrointestinal tract ........................................................................................................ 115
chapter 32: gastroesophageal reflux disease .................................................................................................................. 117
chapter 33: peptic ulcer disease and related disorders .................................................................................................. 119
chapter 34: inflammatory bowel disease ........................................................................................................................ 121
chapter 35: nausea and vomiting .................................................................................................................................... 122
chapter 36: diarrhea, constipation, and irritable bowel syndrome ................................................................................ 125
chapter 37: portal hypertension and cirrhosis ................................................................................................................ 128
chapter 38: drug-induced liver disease........................................................................................................................... 130
chapter 39: pancreatitis .................................................................................................................................................. 131
,chapter 40: viral hepatitis ............................................................................................................................................... 133
chapter 41: celiac disease ............................................................................................................................................... 136
chapter 42: evaluation of kidney function ....................................................................................................................... 138
chapter 43: acute kidney injury....................................................................................................................................... 140
chapter 44: chronic kidney disease ................................................................................................................................. 143
chapter 45: hemodialysis and peritoneal dialysis ........................................................................................................... 145
chapter 46: drug-induced kidney disease........................................................................................................................ 148
chapter 47: glomerulonephritis ....................................................................................................................................... 150
chapter 48: drug therapy individualization for patients with chronic kidney disease .................................................... 152
chapter 49: disorders of sodium and water homeostasis ................................................................................................ 155
chapter 50: disorders of calcium and phosphorus homeostasis...................................................................................... 157
chapter 51: disorders of potassium and magnesium homeostasis................................................................................... 160
chapter 52: acid–base disorders ..................................................................................................................................... 162
chapter 53: evaluation of neurologic illness ................................................................................................................... 166
chapter 54: alzheimer disease......................................................................................................................................... 168
chapter 55: multiple sclerosis ......................................................................................................................................... 171
chapter 56: epilepsy ........................................................................................................................................................ 173
chapter 57: status epilepticus.......................................................................................................................................... 175
chapter 58: acute management of the brain injury patient ............................................................................................. 177
chapter 59: parkinson disease ........................................................................................................................................ 179
chapter 60: pain management ......................................................................................................................................... 181
chapter 61: headache disorders ...................................................................................................................................... 183
chapter 62: assessment of psychiatric disorders............................................................................................................. 185
chapter 63: attention deficit/hyperactivity disorder ........................................................................................................ 187
chapter 64: eating disorders ........................................................................................................................................... 190
chapter 65: substance-related disorders i: overview and depressants, stimulants, and hallucinogens .......................... 192
chapter 66: substance-related disorders ii: alcohol, nicotine, and caffeine ................................................................... 194
chapter 67: schizophrenia ............................................................................................................................................... 196
chapter 68: major depressive disorder ........................................................................................................................... 200
chapter 69: bipolar disorder ........................................................................................................................................... 202
chapter 70: anxiety disorders: generalized anxiety, panic, and social anxiety disorders............................................... 203
chapter 71: posttraumatic stress disorder and obsessive-compulsive disorder .............................................................. 206
chapter 72: sleep–wake disorders ................................................................................................................................... 209
chapter 73: disorders associated with intellectual disabilities ....................................................................................... 211
chapter 74: diabetes mellitus .......................................................................................................................................... 213
chapter 75: thyroid disorders.......................................................................................................................................... 217
chapter 76: adrenal gland disorders............................................................................................................................... 219
chapter 77: pituitary gland disorders ............................................................................................................................. 220
chapter 78: pregnancy and lactation: therapeutic considerations.................................................................................. 222
chapter 79: contraception ............................................................................................................................................... 225
, chapter 80: menstruation-related disorders.................................................................................................................... 228
chapter 81: endometriosis ............................................................................................................................................... 230
chapter 82: hormone therapy in women.......................................................................................................................... 232
chapter 83: erectile dysfunction ...................................................................................................................................... 234
chapter 84: benign prostatic hyperplasia ....................................................................................................................... 237
chapter 85: urinary incontinence .................................................................................................................................... 239
chapter 86: function and evaluation of the immune system ............................................................................................ 241
chapter 87: systemic lupus erythematosus ...................................................................................................................... 247
chapter 88: drug allergy ................................................................................................................................................. 250
chapter 89: solid-organ transplantation ......................................................................................................................... 251
chapter 90: osteoarthritis ............................................................................................................................................... 254
chapter 91: rheumatoid arthritis ..................................................................................................................................... 257
chapter 92: osteoporosis and osteomalacia .................................................................................................................... 259
chapter 93: gout and hyperuricemia ............................................................................................................................... 261
chapter 94: glaucoma...................................................................................................................................................... 262
chapter 95: allergic rhinitis ............................................................................................................................................ 267
chapter 96: acne vulgaris................................................................................................................................................ 269
chapter 97: psoriasis ....................................................................................................................................................... 271
chapter 98: atopic dermatitis .......................................................................................................................................... 272
chapter 99: dermatologic drug reactions and common skin conditions ......................................................................... 273
chapter 100: anemias ...................................................................................................................................................... 279
chapter 101: coagulation disorders ................................................................................................................................ 286
chapter 102: sickle cell disease....................................................................................................................................... 288
chapter 103: drug-induced hematologic disorders ......................................................................................................... 290
chapter 104: laboratory tests to direct antimicrobial pharmacotherapy ........................................................................ 292
chapter 105: antimicrobial regimen selection ................................................................................................................ 296
chapter 106: central nervous system infections .............................................................................................................. 302
chapter 107: lower respiratory tract infections .............................................................................................................. 304
chapter 108: upper respiratory tract infections .............................................................................................................. 309
chapter 109: influenza..................................................................................................................................................... 311
chapter 110: skin and soft-tissue infections .................................................................................................................... 313
chapter 111: infective endocarditis ................................................................................................................................. 316
chapter 112: tuberculosis ................................................................................................................................................ 319
chapter 113: gastrointestinal infections and enterotoxigenic poisonings ....................................................................... 321
chapter 114: intra-abdominal infections......................................................................................................................... 324
chapter 116: urinary tract infections and prostatitis ...................................................................................................... 331
chapter 117: sexually transmitted diseases ..................................................................................................................... 334
chapter 118: bone and joint infections............................................................................................................................ 344
chapter 119: sepsis and septic shock .............................................................................................................................. 345
chapter 120: superficial fungal infections....................................................................................................................... 347
Pharmacotherapy: A Pathophysiologic Approach,11th Edition By Joseph T. Dipiro, Gary C.
Yee, L. Michael Posey, Stuart T. Haines, Thomas D. Nolin, Vicki Ellingrod ||All Chapters With
Verified Answers
11th edition
,table of contents
chapter 1: health literacy and medication use .................................................................................................................... 6
chapter 2: cultural competency ......................................................................................................................................... 11
chapter 3: medication safety principles and practices ...................................................................................................... 16
chapter 4: clinical pharmacokinetics and pharmacodynamics ....................................................................................... 22
chapter 5: pharmacogenetics............................................................................................................................................ 27
chapter 6: pediatrics ......................................................................................................................................................... 33
chapter 7: geriatrics ......................................................................................................................................................... 40
chapter 8: palliative care .................................................................................................................................................. 45
chapter 9: clinical toxicology............................................................................................................................................ 51
chapter 10: clinical management of potential bioterrorism-related conditions................................................................ 56
chapter 11: cardiovascular testing ................................................................................................................................... 61
chapter 12: cardiac arrest ................................................................................................................................................ 61
chapter 13: hypertension .................................................................................................................................................. 65
chapter 14: chronic heart failure ...................................................................................................................................... 70
chapter 15: acute decompensated heart failure ................................................................................................................ 73
chapter 16: stable ischemic heart disease......................................................................................................................... 77
chapter 17: acute coronary syndromes ............................................................................................................................. 80
chapter 18: the arrhythmias .............................................................................................................................................. 85
chapter 19: venous thromboembolism............................................................................................................................... 87
chapter 20: stroke.............................................................................................................................................................. 89
chapter 21: dyslipidemia .................................................................................................................................................. 93
chapter 22: peripheral arterial disease ............................................................................................................................ 95
chapter 23: use of vasopressors and inotropes in the pharmacotherapy of shock............................................................ 96
chapter 24: hypovolemic shock ....................................................................................................................................... 100
chapter 25: introduction to pulmonary function testing ................................................................................................. 103
chapter 26: asthma .......................................................................................................................................................... 106
chapter 27: chronic obstructive pulmonary disease ....................................................................................................... 108
chapter 28: pulmonary arterial hypertension ................................................................................................................. 110
chapter 29: cystic fibrosis ............................................................................................................................................... 111
chapter 30: drug-induced pulmonary diseases ............................................................................................................... 113
chapter 31: evaluation of the gastrointestinal tract ........................................................................................................ 115
chapter 32: gastroesophageal reflux disease .................................................................................................................. 117
chapter 33: peptic ulcer disease and related disorders .................................................................................................. 119
chapter 34: inflammatory bowel disease ........................................................................................................................ 121
chapter 35: nausea and vomiting .................................................................................................................................... 122
chapter 36: diarrhea, constipation, and irritable bowel syndrome ................................................................................ 125
chapter 37: portal hypertension and cirrhosis ................................................................................................................ 128
chapter 38: drug-induced liver disease........................................................................................................................... 130
chapter 39: pancreatitis .................................................................................................................................................. 131
,chapter 40: viral hepatitis ............................................................................................................................................... 133
chapter 41: celiac disease ............................................................................................................................................... 136
chapter 42: evaluation of kidney function ....................................................................................................................... 138
chapter 43: acute kidney injury....................................................................................................................................... 140
chapter 44: chronic kidney disease ................................................................................................................................. 143
chapter 45: hemodialysis and peritoneal dialysis ........................................................................................................... 145
chapter 46: drug-induced kidney disease........................................................................................................................ 148
chapter 47: glomerulonephritis ....................................................................................................................................... 150
chapter 48: drug therapy individualization for patients with chronic kidney disease .................................................... 152
chapter 49: disorders of sodium and water homeostasis ................................................................................................ 155
chapter 50: disorders of calcium and phosphorus homeostasis...................................................................................... 157
chapter 51: disorders of potassium and magnesium homeostasis................................................................................... 160
chapter 52: acid–base disorders ..................................................................................................................................... 162
chapter 53: evaluation of neurologic illness ................................................................................................................... 166
chapter 54: alzheimer disease......................................................................................................................................... 168
chapter 55: multiple sclerosis ......................................................................................................................................... 171
chapter 56: epilepsy ........................................................................................................................................................ 173
chapter 57: status epilepticus.......................................................................................................................................... 175
chapter 58: acute management of the brain injury patient ............................................................................................. 177
chapter 59: parkinson disease ........................................................................................................................................ 179
chapter 60: pain management ......................................................................................................................................... 181
chapter 61: headache disorders ...................................................................................................................................... 183
chapter 62: assessment of psychiatric disorders............................................................................................................. 185
chapter 63: attention deficit/hyperactivity disorder ........................................................................................................ 187
chapter 64: eating disorders ........................................................................................................................................... 190
chapter 65: substance-related disorders i: overview and depressants, stimulants, and hallucinogens .......................... 192
chapter 66: substance-related disorders ii: alcohol, nicotine, and caffeine ................................................................... 194
chapter 67: schizophrenia ............................................................................................................................................... 196
chapter 68: major depressive disorder ........................................................................................................................... 200
chapter 69: bipolar disorder ........................................................................................................................................... 202
chapter 70: anxiety disorders: generalized anxiety, panic, and social anxiety disorders............................................... 203
chapter 71: posttraumatic stress disorder and obsessive-compulsive disorder .............................................................. 206
chapter 72: sleep–wake disorders ................................................................................................................................... 209
chapter 73: disorders associated with intellectual disabilities ....................................................................................... 211
chapter 74: diabetes mellitus .......................................................................................................................................... 213
chapter 75: thyroid disorders.......................................................................................................................................... 217
chapter 76: adrenal gland disorders............................................................................................................................... 219
chapter 77: pituitary gland disorders ............................................................................................................................. 220
chapter 78: pregnancy and lactation: therapeutic considerations.................................................................................. 222
chapter 79: contraception ............................................................................................................................................... 225
, chapter 80: menstruation-related disorders.................................................................................................................... 228
chapter 81: endometriosis ............................................................................................................................................... 230
chapter 82: hormone therapy in women.......................................................................................................................... 232
chapter 83: erectile dysfunction ...................................................................................................................................... 234
chapter 84: benign prostatic hyperplasia ....................................................................................................................... 237
chapter 85: urinary incontinence .................................................................................................................................... 239
chapter 86: function and evaluation of the immune system ............................................................................................ 241
chapter 87: systemic lupus erythematosus ...................................................................................................................... 247
chapter 88: drug allergy ................................................................................................................................................. 250
chapter 89: solid-organ transplantation ......................................................................................................................... 251
chapter 90: osteoarthritis ............................................................................................................................................... 254
chapter 91: rheumatoid arthritis ..................................................................................................................................... 257
chapter 92: osteoporosis and osteomalacia .................................................................................................................... 259
chapter 93: gout and hyperuricemia ............................................................................................................................... 261
chapter 94: glaucoma...................................................................................................................................................... 262
chapter 95: allergic rhinitis ............................................................................................................................................ 267
chapter 96: acne vulgaris................................................................................................................................................ 269
chapter 97: psoriasis ....................................................................................................................................................... 271
chapter 98: atopic dermatitis .......................................................................................................................................... 272
chapter 99: dermatologic drug reactions and common skin conditions ......................................................................... 273
chapter 100: anemias ...................................................................................................................................................... 279
chapter 101: coagulation disorders ................................................................................................................................ 286
chapter 102: sickle cell disease....................................................................................................................................... 288
chapter 103: drug-induced hematologic disorders ......................................................................................................... 290
chapter 104: laboratory tests to direct antimicrobial pharmacotherapy ........................................................................ 292
chapter 105: antimicrobial regimen selection ................................................................................................................ 296
chapter 106: central nervous system infections .............................................................................................................. 302
chapter 107: lower respiratory tract infections .............................................................................................................. 304
chapter 108: upper respiratory tract infections .............................................................................................................. 309
chapter 109: influenza..................................................................................................................................................... 311
chapter 110: skin and soft-tissue infections .................................................................................................................... 313
chapter 111: infective endocarditis ................................................................................................................................. 316
chapter 112: tuberculosis ................................................................................................................................................ 319
chapter 113: gastrointestinal infections and enterotoxigenic poisonings ....................................................................... 321
chapter 114: intra-abdominal infections......................................................................................................................... 324
chapter 116: urinary tract infections and prostatitis ...................................................................................................... 331
chapter 117: sexually transmitted diseases ..................................................................................................................... 334
chapter 118: bone and joint infections............................................................................................................................ 344
chapter 119: sepsis and septic shock .............................................................................................................................. 345
chapter 120: superficial fungal infections....................................................................................................................... 347
